These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12175707)

  • 1. Urocortin has cell-proliferative effects on cardiac non-myocytes.
    Ikeda K; Tojo K; Oki Y; Nakao K
    Life Sci; 2002 Sep; 71(16):1929-38. PubMed ID: 12175707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes.
    Ikeda K; Tojo K; Otsubo C; Udagawa T; Hosoya T; Tajima N; Nakao K; Kawamura M
    Peptides; 2005 Dec; 26(12):2473-81. PubMed ID: 16005543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
    Ikeda K; Tojo K; Udagawa T; Otsubo C; Ishikawa M; Tokudome G; Hosoya T; Tajima N; Nakao K; Kawamura M
    Hypertens Res; 2008 Apr; 31(4):693-706. PubMed ID: 18633182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.
    Nishikimi T; Miyata A; Horio T; Yoshihara F; Nagaya N; Takishita S; Yutani C; Matsuo H; Matsuoka H; Kangawa K
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3031-9. PubMed ID: 11087261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.
    Ikeda K; Tojo K; Sato S; Ebisawa T; Tokudome G; Hosoya T; Harada M; Nakagawa O; Nakao K
    Biochem Biophys Res Commun; 1998 Sep; 250(2):298-304. PubMed ID: 9753624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells.
    Kageyama K; Suda T
    Endocrinology; 2003 Jun; 144(6):2234-41. PubMed ID: 12746280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
    Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
    Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
    Sajdyk TJ; Gehlert DR
    Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of urocortin in rat lung and its effect on pulmonary vascular permeability.
    Wu Y; Xu Y; Zhou H; Tao J; Li S
    J Endocrinol; 2006 Apr; 189(1):167-78. PubMed ID: 16614391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
    Kageyama K; Gaudriault GE; Suda T; Vale WW
    Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone.
    Asaba K; Makino S; Hashimoto K
    Brain Res; 1998 Sep; 806(1):95-103. PubMed ID: 9739115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of endothelin-1 in cardioprotective effects of benidipine.
    Ikeda K; Tojo K; Tokudome G; Akashi T; Hosoya T; Harada M; Nakagawa O; Nakao K
    Hypertens Res; 2000 Sep; 23(5):491-6. PubMed ID: 11016804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells.
    Charalampopoulos I; Androulidaki A; Minas V; Chatzaki E; Tsatsanis C; Notas G; Xidakis C; Kolios G; Kouroumalis E; Margioris AN; Gravanis A
    Neuroendocrinology; 2006; 84(1):49-57. PubMed ID: 17090973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
    J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions.
    Carrarelli P; Luddi A; Funghi L; Arcuri F; Batteux F; Dela Cruz C; Tosti C; Reis FM; Chapron C; Petraglia F
    Reprod Biomed Online; 2016 Oct; 33(4):476-483. PubMed ID: 27567427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation.
    Huang M; Kempuraj D; Papadopoulou N; Kourelis T; Donelan J; Manola A; Theoharides TC
    J Mol Endocrinol; 2009 May; 42(5):397-405. PubMed ID: 19211730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion.
    Scarabelli TM; Pasini E; Stephanou A; Comini L; Curello S; Raddino R; Ferrari R; Knight R; Latchman DS
    J Am Coll Cardiol; 2002 Jul; 40(1):155-61. PubMed ID: 12103270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.
    Li W; Challis JR
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6569-74. PubMed ID: 16174714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.